ALFA Finder| Revenue growth | 11% YoY for FY26. |
|---|---|
| Margins | EBITDA margin at 15.0%; PAT margins under pressure. |
| Demand visibility | Strong tailwinds in chronic disease management and digital health. |
| Management confidence | High on PSP and integrated healthcare model. |
Growth
FY26 Revenue grew 11% to ₹172.9 Cr; however, PAT declined 13% to ₹11.9 Cr. EBITDA remained stable at ₹25.9 Cr.
Outlook
Focusing on scaling PSP platform and eGrameen portal access. Integrated Saarathi Healthcare to lead in disease management services.
Risks
PAT margins compressed from 8.8% to 6.9% YoY; finance costs increased significantly from ₹4.6 Cr to ₹6.6 Cr.
Earnings Call filed with NSE, NSE: QMSMEDI. Summary written with AI assistance from the document.
QMS Medical Allied Services Ltd: key numbers
- Share price
- ₹170.59
- Market cap
- ₹329.9 Cr
- Revenue (annual)
- ₹172.9 Cr
- Net profit (annual)
- ₹11.92 Cr
- P/E (TTM)
- 27.7×Sector 54.5×
- Promoter holding
- 68.11%+0.00% QoQ
- FII holding
- 0.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from QMS Medical Allied Services Ltd
All →QMS Medical Allied Services Annual General Meeting
QMS Medical Allied Services Limited held its 9th Annual General Meeting on September 30, 2026. Shareholders approved a 5% final dividend and adoption of financial results.
QMS Medical Allied Services Acquisition
QMS Medical Allied Services Limited is acquiring BeamOptics Scientific Private Limited. The strategic acquisition aims to expand the company's addressable market in healthcare business.
- Execution
- on or before 30th November, 2027
QMS Medical Allied Services Business Update
QMS Medical Allied Services executed a shareholders' agreement with investors and its subsidiary, Saarathi Healthcare, defining governance rights, veto powers, and share transfer restrictions.
QMS Medical Allied Services Merger & Restructuring
QMS Medical Allied Services Limited approved a composite demerger scheme for its healthcare business and the acquisition of a 100% stake in BeamOptics Scientific Private Limited.
QMS Medical Allied Services Acquisition Worth ₹14.22 Cr
QMS Medical Allied Services Ltd acquired the remaining 24% stake in Saarathi Healthcare Private Limited for Rs. 14.23 Crore, making it a wholly-owned subsidiary.
- Value
- ₹14.22 Cr
QMS Medical Allied Services Other Announcement
QMS Medical Allied Services Limited informed the exchange regarding the dispatch of annual report links to shareholders who haven't registered their email addresses.